A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine.
about
Arbovirosis and potential transmission blocking vaccinesAn antivector vaccine protects against a lethal vector-borne pathogen.A further insight into the sialome of the tropical bont tick, Amblyomma variegatumSalivating for knowledge: potential pharmacological agents in tick salivaTwo novel neuropeptides in innervation of the salivary glands of the black-legged tick, Ixodes scapularis: myoinhibitory peptide and SIFamide.The expression of genes coding for distinct types of glycine-rich proteins varies according to the biology of three metastriate ticks, Rhipicephalus (Boophilus) microplus, Rhipicephalus sanguineus and Amblyomma cajennenseAn insight into the sialotranscriptome of the brown dog tick, Rhipicephalus sanguineusA deep insight into the sialotranscriptome of the gulf coast tick, Amblyomma maculatumDifferential salivary gland transcript expression profile in Ixodes scapularis nymphs upon feeding or flavivirus infectionVaccination against Lyme disease: past, present, and futureTransmission-Blocking Vaccines: Focus on Anti-Vector Vaccines against Tick-Borne DiseasesImmunity against Ixodes scapularis salivary proteins expressed within 24 hours of attachment thwarts tick feeding and impairs Borrelia transmission.Exposed and concealed antigens as vaccine targets for controlling ticks and tick-borne diseases.Strategies for development of vaccines for control of ixodid tick species.Tick vaccines and the control of tick-borne pathogens.Induction of humoral immune response to multiple recombinant Rhipicephalus appendiculatus antigens and their effect on tick feeding success and pathogen transmission.Oral vaccination with vaccinia virus expressing the tick antigen subolesin inhibits tick feeding and transmission of Borrelia burgdorferiAutocrine/paracrine dopamine in the salivary glands of the blacklegged tick Ixodes scapularis.Update on the proteomics of major arthropod vectors of human and animal pathogens.Sialotranscriptomics of Rhipicephalus zambeziensis reveals intricate expression profiles of secretory proteins and suggests tight temporal transcriptional regulation during blood-feeding.Strategies for new and improved vaccines against ticks and tick-borne diseases.New approaches and omics tools for mining of vaccine candidates against vector-borne diseases.Developing Anti-tick Vaccines.A Roadmap for Tick-Borne Flavivirus Research in the "Omics" Era.Identification and characterization of proteins in the Amblyomma americanum tick cement cone.Characterization of a glycine-rich protein from Rhipicephalus microplus: tissue expression, gene silencing and immune recognition.Tick attachment cement - reviewing the mysteries of a biological skin plug system.Immunogenic potential of Rhipicephalus (Boophilus) microplus aquaporin 1 against Rhipicephalus sanguineus in domestic dogs.Rhipicephalus bursa Sialotranscriptomic Response to Blood Feeding and Babesia ovis Infection: Identification of Candidate Protective Antigens.Design of a Lyme Disease Vaccine as an Active Learning Approach in a Novel Interdisciplinary Graduate-Level Course.
P2860
Q27468657-2CA0D3A2-EC56-4B52-8289-B9EB87CF0B72Q27473124-6C932DCD-0838-4318-9E33-A70344503D20Q28741829-3B8DD4D0-072C-4C35-BB40-68432855D008Q33319614-73BB107E-4A71-446E-9059-AB797A7E2375Q33510193-C9FE273D-6711-45A3-88D8-29B81AF3FBE8Q33597079-0DF9BA87-50E8-4E03-B6A5-17DA2B331F91Q33637908-C01A541B-D966-4E18-A715-7210E0AAF087Q34116942-BC01ABAD-F6A8-4B27-AC22-142570292526Q34152051-10F597C6-CFC0-4ADB-9DAF-DABA01F56195Q34327726-8E1F3239-729A-4CB2-9DBA-DFE6E4B65080Q35598662-C7C15FAE-F5B1-4298-8087-E520F309457BQ35785483-7715F865-272C-4E1C-A5E4-267C0E37E601Q36423190-FF346B36-2E88-4E4D-B6FE-89F71DA4D246Q36536631-42C60D4F-01C8-4044-BDC0-3B6FCD7A68A4Q36993703-74E89427-6EC8-4AF7-9B83-9354752F3DF3Q37230869-CA15B45C-CD76-4C8F-90A2-32B79B7668FFQ37610717-44F8268D-F0E1-49B2-8871-6B7E61A0B8DCQ37735065-15125382-6666-49D7-8AA8-E8C689AB4A18Q38053132-B8F4A722-9C7F-401B-B33D-9411E250EF41Q38644251-FF253580-0EBF-4D80-BFED-26BCDC17636BQ38839845-95F8C99B-E311-4AF9-8AED-7053C8D9D5D1Q38888271-897D15A1-89B1-44F1-B392-094138516726Q40801633-16A5C98C-F6EF-4F38-81A0-F6D7DD61040DQ47193184-C9EC5837-1BD0-4037-B13E-9A8216C65A82Q47273902-DA70C8D4-8953-4931-A162-2C09285243EFQ47396680-9784E6E9-E22C-4BCA-B310-09C02DB3C92DQ47422392-A0A0CF21-644F-4156-899A-093966DAF4E3Q51127373-67FB42FE-E6F9-4E36-87DB-04DB7131379EQ54204923-0B17B361-1363-4C8E-BEC8-C7CB03FBF237Q55009910-F763BBE6-8350-4068-97D4-11887859E202
P2860
A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine.
@en
A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine.
@nl
type
label
A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine.
@en
A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine.
@nl
prefLabel
A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine.
@en
A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine.
@nl
P2093
P1433
P1476
A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine.
@en
P2093
Adama R Trimnell
Gillian M Davies
Olga Lissina
Patricia A Nuttall
P304
P356
10.1016/J.VACCINE.2005.03.041
P407
P50
P577
2005-07-01T00:00:00Z